Clinical Trial Update: Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE) [Phase 2]

View source ↗

Summary

This is a completed Phase 2 clinical trial (STRIDE) evaluating strategies to reduce weight and diabetes risk in an underserved population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Psychotic Disorders
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Kaiser Permanente | Conditions: Weight Loss, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED